Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
6.41
+0.24 (3.89%)
At close: Feb 21, 2025, 4:00 PM
6.40
-0.01 (-0.16%)
After-hours: Feb 21, 2025, 4:54 PM EST
Coya Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Coya Therapeutics stock have an average target of 16.25, with a low estimate of 14 and a high estimate of 18. The average target predicts an increase of 153.51% from the current stock price of 6.41.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Coya Therapeutics stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +118.41% | Feb 6, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +134.01% | Feb 6, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +134.01% | Jan 21, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +134.01% | Dec 18, 2024 |
| D. Boral Capital | D. Boral Capital | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +134.01% | Dec 4, 2024 |
Financial Forecast
Revenue This Year
3.67M
from 6.00M
Decreased by -38.81%
Revenue Next Year
5.74M
from 3.67M
Increased by 56.22%
EPS This Year
-1.11
from -0.79
EPS Next Year
-1.33
from -1.11
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 3.9M | 8.8M | 10.5M | |||
| Avg | 3.7M | 5.7M | 5.1M | |||
| Low | 3.5M | 2.4M | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -35.3% | 140.1% | 83.0% | |||
| Avg | -38.8% | 56.2% | -11.1% | |||
| Low | -42.0% | -36.0% | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -1.00 | -1.14 | -1.38 | |||
| Avg | -1.11 | -1.33 | -1.34 | |||
| Low | -1.15 | -1.65 | -1.28 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.